1
|
Buechler CR, Anderson ZJ, Kullberg SA, Miller DD, Ahiskali A, Schut R, Hylwa SA. Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS. JAMA Dermatol 2024; 160:235-236. [PMID: 38055229 DOI: 10.1001/jamadermatol.2023.4727] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2023]
Abstract
This case report describes a man in his 50s with HIV/AIDS who presented with widely scattered recalcitrant mpox lesions.
Collapse
Affiliation(s)
- Connor R Buechler
- Department of Dermatology, University of Minnesota, Minneapolis
- Department of Internal Medicine, University of Minnesota, Minneapolis
| | - Zachary J Anderson
- Department of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota
| | - Sara A Kullberg
- Department of Dermatology, University of Minnesota, Minneapolis
| | - Daniel D Miller
- Department of Dermatology, University of Minnesota, Minneapolis
| | - Aileen Ahiskali
- Department of Pharmacy, Hennepin Healthcare, Minneapolis, Minnesota
| | - Ronald Schut
- Department of Infectious Diseases, Hennepin Healthcare, Minneapolis, Minnesota
| | - Sara A Hylwa
- Department of Dermatology, University of Minnesota, Minneapolis
- Department of Dermatology, Hennepin Healthcare, Minneapolis, Minnesota
| |
Collapse
|
2
|
Fakhoury JW, Buechler CR, Veenstra J. Influence of medical comorbidities, smoking, and alcohol on mycosis fungoides progression and mortality. Int J Dermatol 2024; 63:e33-e35. [PMID: 37997446 DOI: 10.1111/ijd.16931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 10/18/2023] [Accepted: 11/14/2023] [Indexed: 11/25/2023]
Affiliation(s)
| | - Connor R Buechler
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
| | - Jesse Veenstra
- Department of Dermatology, Henry Ford Health, Detroit, MI, USA
| |
Collapse
|
3
|
Ali H, Buechler CR, Sanaullah O, Piranavan P. Pitfalls in antiphospholipid antibody testing: specifically interference from anticoagulation. Clin Rheumatol 2024; 43:821-823. [PMID: 37950774 DOI: 10.1007/s10067-023-06813-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Revised: 11/05/2023] [Accepted: 11/06/2023] [Indexed: 11/13/2023]
Affiliation(s)
- Hammad Ali
- Division of Rheumatology, Department of Medicine, University of Kentucky, 740 S Limestone St., J515 KY Clinic, Lexington, KY, 40536, USA.
| | - Connor R Buechler
- Department of Medicine, University of Minnesota, Minneapolis, MN, USA
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA
| | - Oneeb Sanaullah
- Department of Medicine, Robert Packer Hospital, Sayre, PA, USA
| | - Paramarajan Piranavan
- Division of Rheumatology, Department of Medicine, University of Kentucky, Lexington, KY, USA
| |
Collapse
|
4
|
Ali H, Buechler CR, Sanaullah O, Lucas A, Lohr KL. Iatrogenic ANA: An emerging source of expensive diagnostic confusion. Lupus 2023; 32:299-300. [PMID: 36473694 DOI: 10.1177/09612033221144600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Intravenous immune globulin (IVIg) therapy has been shown to be useful in a multitude of disorders. IVIg is produced from pooled human plasma; therefore, autoantibodies found in the general population are also present in IVIg and transferred to those being transfused. This can prove a particular hazard for screening and diagnostic tests based on autoantibodies. We present a patient who was found to have a positive antinuclear antibody (ANA) titer after multiple IVIg transfusions, resulting in diagnostic confusion and unnecessary workup. A 45-year-old gentleman was diagnosed with atypical CIDP, initiated on a course of IVIg, and sent for inpatient rehabilitation. However, recovery was complicated by multiple readmissions for recurrent weakness, and as part of the workup for other etiologies, an ANA was found to be positive. Sub-serologies and paraneoplastic autoantibody panel were negative. In the absence of clinical symptoms, we recommended continued monitoring and repeat ANA testing 6 months after the last dose of IVIg; as any drug needs 5 half-lives to be eliminated from the body. Clinicians should consider any recent IVIg treatments when evaluating the pre-test probability of detecting an underlying connective tissue disease with ANA screening. Indiscriminate ANA levels in patients recently given IVIg lead to unnecessary and expensive further testing and consultation.
Collapse
Affiliation(s)
- Hammad Ali
- Department of Rheumatology, Division of Internal Medicine, 4530University of Kentucky, Lexington, KY, USA
| | - Connor R Buechler
- Department of Medicine and Dermatology, 144447University of Minnesota, Minneapolis, MN, USA
| | - Oneeb Sanaullah
- Department of Medicine, 23128Robert Packer Hospital, Geisinger University, Sayre, PA, USA
| | - Alexandria Lucas
- College of Medicine, 12252University of Kentucky, Lexington, KY, USA
| | - Kristine L Lohr
- Department of Rheumatology, Division of Internal Medicine, 4530University of Kentucky, Lexington, KY, USA
| |
Collapse
|
5
|
Ali H, Buechler CR, Lohr KM. Calcinosis cutis: need for early and aggressive treatment. Rheumatol Adv Pract 2022; 6:rkac072. [PMID: 36157616 PMCID: PMC9492277 DOI: 10.1093/rap/rkac072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Affiliation(s)
- Hammad Ali
- Division of Rheumatology, Department of Medicine, University of Kentucky , Lexington, KY, USA
| | - Connor R Buechler
- Department of Medicine, University of Minnesota , Minneapolis, MN, USA
- Department of Dermatology, University of Minnesota , Minneapolis, MN, USA
| | - Kristine M Lohr
- Division of Rheumatology, Department of Medicine, University of Kentucky , Lexington, KY, USA
| |
Collapse
|
6
|
Buechler CR, Sagher E, Tisack A, Jacobsen G, Lim HW, McHargue C, Friedman BJ, Mi Q, Ozog DM, Veenstra J. Demographic Factors and Disparate Outcomes in Mycosis Fungoides: Retrospective Analysis of a Racially Diverse 440 Patient Cohort from Detroit, MI, USA. Br J Dermatol 2022; 187:246-248. [DOI: 10.1111/bjd.21034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 01/18/2022] [Accepted: 01/22/2022] [Indexed: 11/29/2022]
Affiliation(s)
| | - Ethan Sagher
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| | - Aaron Tisack
- Wayne State University School of Medicine Detroit MI USA
| | - Gordon Jacobsen
- Department of Public Health Sciences, Henry Ford Health System Detroit MI USA
| | - Henry W. Lim
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| | | | - Ben J. Friedman
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| | - Qing‐Sheng Mi
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| | - David M. Ozog
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| | - Jesse Veenstra
- Department of Dermatology, Henry Ford Health System Detroit MI USA
| |
Collapse
|
7
|
Wadehra A, Chokshi B, Buechler CR, Singh MM. Rapidly Progressive Acute Liver Failure in Relapsed Multiple Myeloma. Cureus 2020; 12:e12346. [PMID: 33520541 PMCID: PMC7837634 DOI: 10.7759/cureus.12346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Multiple myeloma affects upwards of 30,000 people every year and has significant morbidity and mortality. Common complications of the disease involve lytic bone lesions, hypercalcemia, anemia, and acute renal failure. A rare, yet serious, complication includes acute liver failure secondary to hepatic plasma cell infiltration. While this is reported seldom in living patients, it is found in upwards of 40% of patients incidentally on imaging or during autopsy. Conscientious and meticulous monitoring of liver function tests allows for early detection of liver failure in multiple myeloma; thus, allowing for broader therapeutic options overall.
Collapse
Affiliation(s)
- Anshu Wadehra
- Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, USA
| | - Bhavin Chokshi
- Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, USA
| | - Connor R Buechler
- Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, USA
| | - Manmeet M Singh
- Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, USA
| |
Collapse
|
8
|
Veenstra J, Buechler CR, Robinson G, Chapman S, Adelman M, Tisack A, Dimitrion P, Todter E, Kohen L, Lim HW. Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak. J Am Acad Dermatol 2020; 83:1696-1703. [PMID: 32735965 PMCID: PMC7385924 DOI: 10.1016/j.jaad.2020.07.089] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 07/20/2020] [Accepted: 07/23/2020] [Indexed: 12/11/2022]
Abstract
Background Finite clinical data and understanding of COVID-19 immunopathology has led to limited, opinion-based recommendations for the management of patients with immune-mediated inflammatory disease (IMID) receiving immunosuppressive (IS) therapeutics. Objective To determine if IS therapeutic type affects COVID-19 risk among patients with IMID. Methods We conducted a retrospective cohort analysis of Henry Ford Health System patients tested for COVID-19 between February 1 and April 18, 2020, treated with IS medication for IMID. Therapeutic class of IS medication, comorbidities, and demographic factors were combined into multivariate models to determine predictors of COVID-19 infection, admission, ventilation, and mortality. Results Of 213 patients with IMID, 36.2% tested positive for COVID-19, and they had no greater odds of being hospitalized or requiring ventilation relative to the general population. No IS therapeutic worsened the course of disease after multivariate correction, although multidrug regimens and biologics predicted an increased and decreased rate of hospitalization, respectively, with the latter driven by tumor necrosis factor α inhibitors. Limitations A single-center study somewhat limits the generalization to community-based settings. Only patients tested for COVID-19 were analyzed. Conclusion IS therapies for IMIDs are not associated with a significantly greater risk of SARS-CoV-2 or severe sequelae when controlling for other factors, and tumor necrosis factor α inhibitors may decrease the odds of severe infection.
Collapse
Affiliation(s)
- Jesse Veenstra
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan.
| | | | | | - Stephanie Chapman
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan
| | | | - Aaron Tisack
- Wayne State University School of Medicine, Detroit, Michigan
| | - Peter Dimitrion
- Wayne State University School of Medicine, Detroit, Michigan
| | - Erika Todter
- Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan
| | - Laurie Kohen
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan
| | - Henry W Lim
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan
| |
Collapse
|
9
|
Buechler CR, Ukani A, Elsharawi R, Gable J, Petersen A, Franklin M, Chung R, Bell J, Manly A, Hefzi N, Carpenter D, Bryce R. Barriers, beliefs, and practices regarding hygiene and vaccination among the homeless during a hepatitis A outbreak in Detroit, MI. Heliyon 2020; 6:e03474. [PMID: 32258449 PMCID: PMC7109626 DOI: 10.1016/j.heliyon.2020.e03474] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 11/25/2019] [Accepted: 02/10/2020] [Indexed: 01/15/2023] Open
Abstract
Appropriate hygiene practices and vaccine acceptance are key factors impacting the health of homeless individuals. A recent outbreak of hepatitis A in Michigan, especially impacting Detroit, prompted us to investigate the practices and attitudes of Detroit's homeless population toward hygiene measures and vaccinations, as well as barriers to such resources. We developed a questionnaire as a means to collect our data, and participants were interviewed at shelters and soup kitchens. While the majority of participants adhered to healthy hygiene practices, approximately 89% reported barriers to accessing public showers. More than half the participants (64%) reported receiving their hepatitis A vaccine prior to the study, while 23% reported previously refusing or hesitating to receive vaccinations. Despite an overall favorable adherence to hygiene practices, substantial barriers are yet to be overcome. Moreover, active measures should be taken to establish higher levels of trust between providers and the homeless to encourage vaccine acceptance.
Collapse
Affiliation(s)
- Connor R Buechler
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Anita Ukani
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Radwa Elsharawi
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Jessica Gable
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Anneliese Petersen
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Michael Franklin
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Raymond Chung
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Jedidiah Bell
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Amanda Manly
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Nousha Hefzi
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| | - Dean Carpenter
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Neighborhood Service Organization, Detroit, Michigan, 48213, USA
| | - Richard Bryce
- Street Medicine Detroit, Detroit, Michigan, 48201, USA.,Wayne State University School of Medicine, Detroit, Michigan, 48201, USA
| |
Collapse
|
10
|
Heffron AS, Mohr EL, Baker D, Haj AK, Buechler CR, Bailey A, Dudley DM, Newman CM, Mohns MS, Koenig M, Breitbach ME, Rasheed M, Stewart LM, Eickhoff J, Pinapati RS, Beckman E, Li H, Patel J, Tan JC, O’Connor DH. Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques. PLoS Negl Trop Dis 2018; 12:e0006903. [PMID: 30481182 PMCID: PMC6286021 DOI: 10.1371/journal.pntd.0006903] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Revised: 12/07/2018] [Accepted: 10/04/2018] [Indexed: 12/11/2022] Open
Abstract
The specificity of the antibody response against Zika virus (ZIKV) is not well-characterized. This is due, in part, to the antigenic similarity between ZIKV and closely related dengue virus (DENV) serotypes. Since these and other similar viruses co-circulate, are spread by the same mosquito species, and can cause similar acute clinical syndromes, it is difficult to disentangle ZIKV-specific antibody responses from responses to closely-related arboviruses in humans. Here we use high-density peptide microarrays to profile anti-ZIKV antibody reactivity in pregnant and non-pregnant macaque monkeys with known exposure histories and compare these results to reactivity following DENV infection. We also compare cross-reactive binding of ZIKV-immune sera to the full proteomes of 28 arboviruses. We independently confirm a purported ZIKV-specific IgG antibody response targeting ZIKV nonstructural protein 2B (NS2B) that was recently reported in ZIKV-infected people and we show that antibody reactivity in pregnant animals can be detected as late as 127 days post-infection (dpi). However, we also show that these responses wane over time, sometimes rapidly, and in one case the response was elicited following DENV infection in a previously ZIKV-exposed animal. These results suggest epidemiologic studies assessing seroprevalence of ZIKV immunity using linear epitope-based strategies will remain challenging to interpret due to susceptibility to false positive results. However, the method used here demonstrates the potential for rapid profiling of proteome-wide antibody responses to a myriad of neglected diseases simultaneously and may be especially useful for distinguishing antibody reactivity among closely related pathogens.
Collapse
Affiliation(s)
- Anna S. Heffron
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Emma L. Mohr
- Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States of America
| | - David Baker
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Amelia K. Haj
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Connor R. Buechler
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Adam Bailey
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Dawn M. Dudley
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Christina M. Newman
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Mariel S. Mohns
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Michelle Koenig
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Meghan E. Breitbach
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Mustafa Rasheed
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Laurel M. Stewart
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Jens Eickhoff
- Department of Biostatistics & Medical Informatics, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Richard S. Pinapati
- Technology Innovation, Roche Sequencing Solutions, Madison, WI, United States of America
| | - Erica Beckman
- Technology Innovation, Roche Sequencing Solutions, Madison, WI, United States of America
| | - Hanying Li
- Technology Innovation, Roche Sequencing Solutions, Madison, WI, United States of America
| | - Jigar Patel
- Technology Innovation, Roche Sequencing Solutions, Madison, WI, United States of America
| | - John C. Tan
- Technology Innovation, Roche Sequencing Solutions, Madison, WI, United States of America
| | - David H. O’Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, United States of America
| |
Collapse
|
11
|
Newman CM, Dudley DM, Aliota MT, Weiler AM, Barry GL, Mohns MS, Breitbach ME, Stewart LM, Buechler CR, Graham ME, Post J, Schultz-Darken N, Peterson E, Newton W, Mohr EL, Capuano S, O'Connor DH, Friedrich TC. Oropharyngeal mucosal transmission of Zika virus in rhesus macaques. Nat Commun 2017; 8:169. [PMID: 28765581 PMCID: PMC5539107 DOI: 10.1038/s41467-017-00246-8] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 06/12/2017] [Indexed: 11/09/2022] Open
Abstract
Zika virus is present in urine, saliva, tears, and breast milk, but the transmission risk associated with these body fluids is currently unknown. Here we evaluate the risk of Zika virus transmission through mucosal contact in rhesus macaques. Application of high-dose Zika virus directly to the tonsils of three rhesus macaques results in detectable plasma viremia in all animals by 2 days post-exposure; virus replication kinetics are similar to those observed in animals infected subcutaneously. Three additional macaques inoculated subcutaneously with Zika virus served as saliva donors to assess the transmission risk from contact with oral secretions from an infected individual. Seven naive animals repeatedly exposed to donor saliva via the conjunctivae, tonsils, or nostrils did not become infected. Our results suggest that there is a risk of Zika virus transmission via the mucosal route, but that the risk posed by oral secretions from individuals with a typical course of Zika virus infection is low. Zika virus (ZIKV) is present in body fluids, including saliva, but transmission risk through mucosal contact is not well known. Here, the authors show that oropharyngeal mucosal infection of macaques with a high ZIKV dose results in viremia, but that transmission risk from saliva of infected animals is low.
Collapse
Affiliation(s)
- Christina M Newman
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Dawn M Dudley
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Matthew T Aliota
- Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, 2015 Linden Dr., Madison, WI, 53706, USA
| | - Andrea M Weiler
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Gabrielle L Barry
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Mariel S Mohns
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Meghan E Breitbach
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Laurel M Stewart
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Connor R Buechler
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Michael E Graham
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA
| | - Jennifer Post
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Nancy Schultz-Darken
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Eric Peterson
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Wendy Newton
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Emma L Mohr
- Department of Pediatrics, University of Wisconsin, University of Wisconsin Clinical Science Center, 600 Highland Ave., Madison, WI, 53792, USA
| | - Saverio Capuano
- Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - David H O'Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, 3170 UW Medical Foundation Centennial Building, 1685 Highland Ave., Madison, WI, 53705, USA.,Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA
| | - Thomas C Friedrich
- Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, 2015 Linden Dr., Madison, WI, 53706, USA. .,Wisconsin National Primate Research Center, University of Wisconsin, 1220 Capitol Ct., Madison, WI, 53715, USA.
| |
Collapse
|
12
|
Aliota MT, Dudley DM, Newman CM, Mohr EL, Gellerup DD, Breitbach ME, Buechler CR, Rasheed MN, Mohns MS, Weiler AM, Barry GL, Weisgrau KL, Eudailey JA, Rakasz EG, Vosler LJ, Post J, Capuano S, Golos TG, Permar SR, Osorio JE, Friedrich TC, O’Connor SL, O’Connor DH. Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques. PLoS Negl Trop Dis 2016; 10:e0005168. [PMID: 27911897 PMCID: PMC5135040 DOI: 10.1371/journal.pntd.0005168] [Citation(s) in RCA: 112] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2016] [Accepted: 11/07/2016] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Zika virus (ZIKV; Flaviviridae, Flavivirus) was declared a public health emergency of international concern by the World Health Organization (WHO) in February 2016, because of the evidence linking infection with ZIKV to neurological complications, such as Guillain-Barre Syndrome in adults and congenital birth defects including microcephaly in the developing fetus. Because development of a ZIKV vaccine is a top research priority and because the genetic and antigenic variability of many RNA viruses limits the effectiveness of vaccines, assessing whether immunity elicited against one ZIKV strain is sufficient to confer broad protection against all ZIKV strains is critical. Recently, in vitro studies demonstrated that ZIKV likely circulates as a single serotype. Here, we demonstrate that immunity elicited by African lineage ZIKV protects rhesus macaques against subsequent infection with Asian lineage ZIKV. METHODOLOGY/PRINCIPAL FINDINGS Using our recently developed rhesus macaque model of ZIKV infection, we report that the prototypical ZIKV strain MR766 productively infects macaques, and that immunity elicited by MR766 protects macaques against heterologous Asian ZIKV. Furthermore, using next generation deep sequencing, we found in vivo restoration of a putative N-linked glycosylation site upon replication in macaques that is absent in numerous MR766 strains that are widely being used by the research community. This reversion highlights the importance of carefully examining the sequence composition of all viral stocks as well as understanding how passage history may alter a virus from its original form. CONCLUSIONS/SIGNIFICANCE An effective ZIKV vaccine is needed to prevent infection-associated fetal abnormalities. Macaques whose immune responses were primed by infection with East African ZIKV were completely protected from detectable viremia when subsequently rechallenged with heterologous Asian ZIKV. Therefore, these data suggest that immunogen selection is unlikely to adversely affect the breadth of vaccine protection, i.e., any Asian ZIKV immunogen that protects against homologous challenge will likely confer protection against all other Asian ZIKV strains.
Collapse
Affiliation(s)
- Matthew T. Aliota
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Dawn M. Dudley
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Christina M. Newman
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Emma L. Mohr
- Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison, Wisconsin, United States of America
| | - Dane D. Gellerup
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Meghan E. Breitbach
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Connor R. Buechler
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Mustafa N. Rasheed
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Mariel S. Mohns
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Andrea M. Weiler
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Gabrielle L. Barry
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Kim L. Weisgrau
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Josh A. Eudailey
- Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America
| | - Eva G. Rakasz
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Logan J. Vosler
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Jennifer Post
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Saverio Capuano
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Thaddeus G. Golos
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Departments of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Departments of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Sallie R. Permar
- Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America
- Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States of America
| | - Jorge E. Osorio
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Thomas C. Friedrich
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - Shelby L. O’Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
| | - David H. O’Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
- * E-mail:
| |
Collapse
|
13
|
Ericsen AJ, Lauck M, Mohns MS, DiNapoli SR, Mutschler JP, Greene JM, Weinfurter JT, Lehrer-Brey G, Prall TM, Gieger SM, Buechler CR, Crosno KA, Peterson EJ, Reynolds MR, Wiseman RW, Burwitz BJ, Estes JD, Sacha JB, Friedrich TC, Brenchley JM, O’Connor DH. Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication. PLoS Pathog 2016; 12:e1006048. [PMID: 27926931 PMCID: PMC5142784 DOI: 10.1371/journal.ppat.1006048] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2016] [Accepted: 11/08/2016] [Indexed: 12/13/2022] Open
Abstract
Within the first three weeks of human immunodeficiency virus (HIV) infection, virus replication peaks in peripheral blood. Despite the critical, causal role of virus replication in determining transmissibility and kinetics of progression to acquired immune deficiency syndrome (AIDS), there is limited understanding of the conditions required to transform the small localized transmitted founder virus population into a large and heterogeneous systemic infection. Here we show that during the hyperacute "pre-peak" phase of simian immunodeficiency virus (SIV) infection in macaques, high levels of microbial DNA transiently translocate into peripheral blood. This, heretofore unappreciated, hyperacute-phase microbial translocation was accompanied by sustained reduction of lipopolysaccharide (LPS)-specific antibody titer, intestinal permeability, increased abundance of CD4+CCR5+ T cell targets of virus replication, and T cell activation. To test whether increasing gastrointestinal permeability to cause microbial translocation would amplify viremia, we treated two SIV-infected macaque 'elite controllers' with a short-course of dextran sulfate sodium (DSS)-stimulating a transient increase in microbial translocation and a prolonged recrudescent viremia. Altogether, our data implicates translocating microbes as amplifiers of immunodeficiency virus replication that effectively undermine the host's capacity to contain infection.
Collapse
Affiliation(s)
- Adam J. Ericsen
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
- Virology Training Program, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Michael Lauck
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Mariel S. Mohns
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Sarah R. DiNapoli
- Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States Of America
| | - James P. Mutschler
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| | - Justin M. Greene
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Jason T. Weinfurter
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Gabrielle Lehrer-Brey
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| | - Trent M. Prall
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| | - Samantha M. Gieger
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Connor R. Buechler
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Kristin A. Crosno
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| | - Eric J. Peterson
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| | - Matthew R. Reynolds
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Roger W. Wiseman
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Benjamin J. Burwitz
- Vaccine & Gene Therapy Institute, Oregon National Primate Research Center, and Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, United States Of America
| | - Jacob D. Estes
- AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States Of America
| | - Jonah B. Sacha
- Vaccine & Gene Therapy Institute, Oregon National Primate Research Center, and Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, United States Of America
| | - Thomas C. Friedrich
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
- Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
| | - Jason M. Brenchley
- Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States Of America
| | - David H. O’Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States Of America
- Wisconsin National Primate Research Center, Madison, Wisconsin, United States Of America
| |
Collapse
|
14
|
Lynn GM, Laga R, Darrah PA, Ishizuka AS, Balaci AJ, Dulcey AE, Pechar M, Pola R, Gerner MY, Yamamoto A, Buechler CR, Quinn KM, Smelkinson MG, Vanek O, Cawood R, Hills T, Vasalatiy O, Kastenmuller K, Francica JR, Stutts L, Tom JK, Ryu KA, Esser-Kahn AP, Etrych T, Fisher KD, Seymour LW, Seder RA. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity. Nat Biotechnol 2015; 33:1201-10. [PMID: 26501954 PMCID: PMC5842712 DOI: 10.1038/nbt.3371] [Citation(s) in RCA: 309] [Impact Index Per Article: 34.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2015] [Accepted: 09/14/2015] [Indexed: 02/06/2023]
Abstract
The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer-TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.
Collapse
Affiliation(s)
- Geoffrey M. Lynn
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
- Department of Oncology, University of Oxford, Oxford, United Kingdom
| | - Richard Laga
- Department of Oncology, University of Oxford, Oxford, United Kingdom
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Patricia A. Darrah
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Andrew S. Ishizuka
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Alexandra J. Balaci
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Andrés E. Dulcey
- Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA
| | - Michal Pechar
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Robert Pola
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Michael Y. Gerner
- Lymphocyte Biology Section, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Ayako Yamamoto
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Connor R. Buechler
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Kylie M. Quinn
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Margery G. Smelkinson
- Biological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Ondrej Vanek
- Department of Biochemistry, Faculty of Science, Charles University in Prague, Prague, Czech Republic
| | - Ryan Cawood
- Department of Oncology, University of Oxford, Oxford, United Kingdom
| | - Thomas Hills
- Department of Oncology, University of Oxford, Oxford, United Kingdom
| | - Olga Vasalatiy
- Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, MD, USA
| | - Kathrin Kastenmuller
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Joseph R. Francica
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - Lalisa Stutts
- Department of Chemistry, University of California Irvine, Irvine, California, USA
| | - Janine K. Tom
- Department of Chemistry, University of California Irvine, Irvine, California, USA
| | - Keun Ah Ryu
- Department of Chemistry, University of California Irvine, Irvine, California, USA
| | - Aaron P. Esser-Kahn
- Department of Chemistry, University of California Irvine, Irvine, California, USA
| | - Tomas Etrych
- Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
| | - Kerry D. Fisher
- Department of Oncology, University of Oxford, Oxford, United Kingdom
| | | | - Robert A. Seder
- Vaccine research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
15
|
Pierce MS, Buechler CR, Sorensen LB, Turner JJ, Kevan SD, Jagla EA, Deutsch JM, Mai T, Narayan O, Davies JE, Liu K, Dunn JH, Chesnel KM, Kortright JB, Hellwig O, Fullerton EE. Disorder-induced microscopic magnetic memory. Phys Rev Lett 2005; 94:017202. [PMID: 15698125 DOI: 10.1103/physrevlett.94.017202] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2003] [Indexed: 05/24/2023]
Abstract
Using coherent x-ray speckle metrology, we have measured the influence of disorder on major loop return point memory (RPM) and complementary point memory (CPM) for a series of perpendicular anisotropy Co/Pt multilayer films. In the low disorder limit, the domain structures show no memory with field cycling--no RPM and no CPM. With increasing disorder, we observe the onset and the saturation of both the RPM and the CPM. These results provide the first direct ensemble-sensitive experimental study of the effects of varying disorder on microscopic magnetic memory and are compared against the predictions of existing theories.
Collapse
Affiliation(s)
- M S Pierce
- Department of Physics, University of Washington, Seattle, WA 98195, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|